Your browser doesn't support javascript.
loading
Concurrent pembrolizumab with AVD for untreated classic Hodgkin lymphoma.
Lynch, Ryan C; Ujjani, Chaitra S; Poh, Christina; Warren, Edus H; Smith, Stephen D; Shadman, Mazyar; Till, Brian; Raghunathan, Vikram M; Alig, Stefan; Alizadeh, Ash A; Gulhane, Avanti; Chen, Delphine L; Tseng, Yolanda; Coye, Hilary; Shelby, Megan; Ottemiller, Susan; Keo, Sarith; Verni, Kaitlin; Du, Hongyan; Vandermeer, Jacquelin; Gaston, Ashley; Rasmussen, Heather; Martin, Paul; Marzbani, Edmond; Voutsinas, Jenna; Gopal, Ajay K.
Afiliação
  • Lynch RC; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Ujjani CS; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Poh C; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Warren EH; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Smith SD; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Shadman M; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Till B; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Raghunathan VM; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Alig S; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Alizadeh AA; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Gulhane A; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Chen DL; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Tseng Y; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Coye H; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Shelby M; Division of Oncology, Stanford University, Stanford, CA.
  • Ottemiller S; Division of Oncology, Stanford University, Stanford, CA.
  • Keo S; Department of Radiology, University of Washington, Seattle, WA.
  • Verni K; Department of Radiology, University of Washington, Seattle, WA.
  • Du H; Clinical Research Division, Fred Hutch Cancer Center, Seattle, WA.
  • Vandermeer J; Department of Radiation Oncology, University of Washington, Seattle, WA.
  • Gaston A; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Rasmussen H; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Martin P; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Marzbani E; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Voutsinas J; Division of Medical Oncology, University of Washington, Seattle, WA.
  • Gopal AK; Division of Medical Oncology, University of Washington, Seattle, WA.
Blood ; 141(21): 2576-2586, 2023 05 25.
Article em En | MEDLINE | ID: mdl-36913694

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin Limite: Humans Idioma: En Revista: Blood Ano de publicação: 2023 Tipo de documento: Article